Cases & Deals

Genticel completes IPO on regulated markets of Euronext in Paris and Brussels

Clients Genticel S.A.

Jones Day advised Genticel, S.A., a developer of therapeutic vaccines against HPV infection with high-risk types, in connection with its €34.5 million (US$47.8 million) initial public offering of Ordinary Shares on the regulated markets of Euronext in Paris and in Brussels. Oddo & Cie and KBC Securities NV acted as joint book-running managers.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.